BCYC
Bicycle Therapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$3.65
−0.82%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 15.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.50x
- Price / sales
- 4.17x
- Price / cash flow
- -1.24x
Enterprise value
- Enterprise value
- -$240.9M
- EV / sales
- -3.94x
- EV / EBITDA
- 1.31x
- EV / EBIT
- 1.15x
- Market cap
- $255.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026